Replies to post #135850 on Biotech Values

[mcbio]

Nplate Sales:

Sales of Nplate® (romiplostim) increased 23 percent to $80 million in the fourth quarter of 2011 versus $65 million in the fourth quarter of 2010.

Presumably bodes well for LGND and Promacta?

[ghmm]

Nplate Sales:

Sales of Nplate® (romiplostim) increased 38 percent to $90 million in the first quarter of 2012 versus $65 million in the first quarter of 2011. These increases were driven primarily by global unit growth.

http://www.amgen.com/media/media_pr_detail.jsp?releaseID=1686784